Skip to content
- Strive, Inc. agreed to acquire Semler Scientific in an all-stock deal with a significant premium.
- Strive expanded its Bitcoin holdings to nearly 6,000, strengthening its treasury position.
- The combined company will focus on both Bitcoin growth and preventative diagnostics.
According to the report, Strive, Inc. has reached a definitive agreement to acquire Semler Scientific, Inc. in a stock-based deal that reshapes the future of both firms. The move underscores Strive’s intent to expand beyond finance and place itself among the fastest growing Bitcoin treasury holders.
The combined company also seeks to improve the place for Semler Scientific in diagnostics as part of a twofold strategy for financial and healthcare growth. The deal establishes the value for Semler Scientific at a premium of 210 percent, or roughly $90.52 a share.
Each holder of Semler Scientific stock will get 21.05 Class A shares of Strive. The merger has been approved by both boards and the companies hope to close once customary and regulatory conditions are satisfied.
Strive Bitcoin Strategy Uses Equity Instead of Debt
As part of the merger, Strive also undertook a notable purchase for the balance sheet. The firm revealed the acquisition of 5,816 Bitcoin at an average price of $116,047. The combined cost stood at $675 million with fees, increasing Strive’s Bitcoin holding to 5,886.
After the acquisition of Semler Scientific, the combined corporation would control more than 10,900 Bitcoin, becoming one of the leading corporate owners in the world. Strive wants to stand out for the unique leverage model. The company explained favoring perpetual preferred equity over regular debt.
This strategy offers flexibility without exposing shareholders to maturity risk typical of traditional debt. The management considers this strategy as facilitating value growth by increasing Bitcoin per share and boosting long-term returns.
Beyond the financial aspect, the merger also bears a health implication. The new company would seek to capitalize or expand the diagnostics enterprise of Semler Scientific. The focus would include preventative care as well as the early detection of chronic diseases.
Strive and Semler Join Forces for Growth
By fusing medical innovation with financial prowess, the company aims at creating a development platform which grows further than the mission-based as well as the profit-based side. Leadership from the two ends shall dictate the company’s future.
Strive’s board and leadership will remain, and the board of the merged company will also see the addition of Eric Semler, the Executive Chairman of Semler Scientific. Advisors for the deal are Davis Polk & Wardwell LLP and Cantor Fitzgerald.
This acquisition is a harbinger from Strive that it wishes to accelerate as a Bitcoin behemoth while starting a new era of preventative diagnostics. The dual-track strategy betrays a broader vision: a harmonious fusion of blockchain-based financial breakthroughs with public health advancements.
Related Reading: Metaplanet Expands Into U.S. and Japan as Bitcoin Holdings Hit $2.3 Billion
